Ozempic Is a Hit. So Why Is the Drugmaker’s C...

Allbirds shot to fame with eco-friendly wool sneakers, leaning on its popularity to pursue a hyperfast growth model. But after a series of missteps, the startup that was once a cultural symbol of cool is now a standout example of a hot company that lost its way. WSJ’s Suzanne Kap ...  Show more

For years, big food and beverage companies like PepsiCo leaned hard into launching new, healthy food products. But recently, PepsiCo has decided to double down on its flagship chips and soda and is looking to make those products healthier. WSJ's Jennifer Maloney explains what it ...  Show more

President Trump struck a deal with Big Pharma for $150 GLP-1 drugs… a total euro move.On the 10th anniversary of the Baby Shark video… its owner PinkFong IPO’d at a $400 million valuation.Lyft’s CEO celebrated their best quarter yet… by joining The Best One Yet in-studioLooksMapp ...  Show more

It’s been a turbulent fortnight for corporate leadership, with sudden CEO exits at companies like HUL, Coca Cola bottler HCCB, L’Oréal, Diageo, Kenvue and WPP. In this episode of The Morning Brief, host Ratna Bhushan speaks to ET’s Associate Editor Arijit Barman and Vibhav Dhawan ...  Show more

Episode 414: Neal and Toby break down with Nike CEO John Donahoe announces he is retiring after the company's struggling sales. Plus, the guys explain why every single board member resigned from 23andMe this week. Then, Olive Garden cuts a deal with Uber to deliver bread sticks a ...  Show more

Fresh news on the tariff front when it comes to potential deals – and hopes of relief for the automakers… Carl Quintanilla, Sara Eisen, and David Faber broke down the latest from the White House, alongside the morning’s biggest earnings stories: from GM pulling guidance and de ...